Literature DB >> 10407113

Visualisation of AMPA binding sites in the brain stem of normotensive and hypertensive rats.

M A Ashworth-Preece1, F Chen, B Jarrott, A J Lawrence.   

Abstract

The present study has employed in vitro receptor autoradiography with (S)-[(3)H]-5-fluorowillardiine (10 nM) to visualise the presence of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites in the brain stems of adult (16-18 weeks) normotensive (Wistar-Kyoto (WKY) and Don Ryu (DRY)) and Spontaneously Hypertensive (SHR) rats. Similar topographic distribution and density of (S)-[(3)H]-5-fluorowillardiine binding was observed in the nucleus tractus solitarius (NTS) of all three strains. Specific (S)-[(3)H]-5-fluorowillardiine binding sites were also visualised in sections of nodose ganglion from adult WKY rats, demonstrating that vagal afferent perikarya possess AMPA binding sites. However, while unilateral vagal deafferentation did not result in a significant decrease in binding site density in the caudal half of the rat NTS, the visualisation of AMPA binding sites on the nodose ganglion is consistent with the existence of a population of binding sites on vagal afferent terminals. In the caudal half of the rat NTS, AMPA binding sites appear to be predominantly postsynaptic in nature. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407113     DOI: 10.1016/s0006-8993(99)01560-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Sustained hypertension increases the density of AMPA receptor subunit, GluR1, in baroreceptive regions of the nucleus tractus solitarii of the rat.

Authors:  Sam M Hermes; Jennifer L Mitchell; Marc B Silverman; Patrick J Lynch; Brenda L McKee; Timothy W Bailey; Michael C Andresen; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-24       Impact factor: 3.252

Review 2.  Plasticity in glutamatergic NTS neurotransmission.

Authors:  David D Kline
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.